Location History:
- College Station, TX (US) (2015 - 2018)
- San Diego, CA (US) (2022 - 2024)
Company Filing History:
Years Active: 2015-2024
Title: **Innovative Contributions of Dwight Baker in Sequencing Technology**
Introduction
Dwight Baker is an accomplished inventor based in San Diego, California, with a significant record of innovation in the biotechnology field. With two patents to his name, Baker has made notable strides in the development of unique molecular identifiers aimed at advancing sequencing methods.
Latest Patents
Baker's most recent patents focus on "Universal short adapters with variable length non-random unique molecular identifiers." These groundbreaking methods, systems, and computer program products are designed for determining sequences of interest using unique molecular indexes (UMIs). These UMIs are integrated with individual polynucleotide fragments, making it possible to analyze sequences with low allele frequencies or lengthy sequences. In various implementations, the patents include variable-length nonrandom UMIs (vNRUMIs), along with the methodologies for creating and utilizing sequencing adapters that incorporate these innovative identifiers.
Career Highlights
Dwight Baker is currently affiliated with Illumina Corporation, a leader in the field of genetic sequencing and genomics. His work continues to impact the industry significantly, paving the way for more efficient and accurate sequencing techniques.
Collaborations
Baker collaborates with talented individuals such as Chen Zhao and Kevin Eric Wu, contributing to a rich environment of research and innovation. These partnerships enhance the development of advanced technologies and methods in molecular biology.
Conclusion
Dwight Baker exemplifies the spirit of innovation in biotechnology with his unique patents and contributions to the field of sequencing technology. His work at Illumina Corporation, alongside esteemed colleagues, showcases his commitment to driving advancements in genetic research and development. Baker's innovative solutions, particularly in the realm of unique molecular identifiers, are set to have a lasting impact on the future of sequencing methodologies.